Boehringer Hits Sun Pharma With Suit Over Diabetes Generic
Boehringer Ingelheim has accused Sun Pharmaceutical of infringing its patents covering the Type 2 diabetes treatment Trijardy XR in a lawsuit in Delaware federal court....To view the full article, register now.
Already a subscriber? Click here to view full article